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Genetic and Chemical Characterisation of the Cornexistin Pathway 
Provides Further Insight into Maleidride Biosynthesis 
Katherine Williams,a Agnieszka. J. Szwalbe,b Claire Dickson,b Tim R. Desson,c Nicholas. P. 
Mulholland,c Jason. L. Vincent,c John. M. Clough,c Andrew. M. Bailey,d Craig. P. Butts,b Christine. L. 
Willis,b Thomas. J. Simpsonb and Russell. J. Coxa,b* 
The biosynthesis of the herbicide cornexistin in the fungus Paecilomyces 
variotii was investigated by full sequencing of its genome, knockout of key 
genes within its biosynthetic gene cluster and isolation and identification 
of intermediate compounds. The general biosynthetic pathway resembles 
that of byssochlamic acid and other nonadrides in the early stages, but 
differs in requiring fewer enzymes in the key nonadride dimerisation step, 
and in the removal of one maleic anhydride moiety. 
Weeds are significant pests of wheat, maize and soybean due 
to competition for inorganic nutrients.1 Herbicides which 
target weeds without harming these crops could improve food 
security. Cornexistin 1, produced by the fungus Paecilomyces 
variotii, is a potent wide-spectrum herbicide against weeds but 
with low activity against Zea mays (maize), and thus shows 
considerable promise as a commercial herbicide.2 Cornexistin 
1 is a maleidride: these are 7-, 8- and 9-membered carbocyclic 
rings fused to one or (usually) two maleic anhydrides.3 Related 
compounds include agnestadride A 2 (heptadride),3 
viburspiran 34 (octadride) and byssochlamic acid 4 
(nonadride).3,5 Maleic anhydrides have been associated with a 
wide range of useful biological properties.6 We recently 
elucidated the complete biosynthetic pathway of byssochlamic 
acid 4.5 The first step of the pathway is catalysed by a fungal 
highly reducing polyketide synthase (hrPKS),7 and subsequent 
steps involve a citrate synthase (CS) homologue and a 2-
methyl citrate dehydratase (2MCD) to create the key 
intermediate 5. Oikawa also reported a similar early pathway 
towards the phomoidrides8 and Tang and coworkers have 
shown that the biosynthesis of rubratoxins follows the same 
pathway.9 Construction of the carbocyclic ring appears to be 
catalysed by pairs of enzymes with homology to phosphatidyl-
ethanolamine binding proteins (PEBP) and ketosteroid 
isomerase-like enzymes (KI). 
 The titre of 1 is low (typically < 10 mgL-1 in our hands) and 
no total synthesis of 1 has been reported.10 We rationalised 
that the biosynthesis of 1 should be encoded by a biosynthetic 
gene cluster (BGC) highly similar to that involved in the 
production of 4 in Byssochlamys fulva. We thus set out to 
investigate the biosynthesis of 1 via genome sequencing and 
gene disruption experiments with the aim of increasing its titre 
and producing structurally related compounds. 
 
 We sequenced the genome of P. variotii, using Illumina 
paired-end and mate-pair technology to reveal a genome of 
approximately 35 Mb contained on 41 scaffolds with an N50 of 
3.3 Mb. BLAST analyses identified a single putative maleidride-
type BGC (Figure 1). Predicted coding sequences were 
annotated using BLAST and InterPro (Table 1). The putative 
cornexistin 1 BGC11 was compared to the previously identified 
byssochlamic acid BGC,5 as well as to two putative maleidride 
BGCs from Talaromyces stipitatus and one identified from 
several Cochliobolus species, using Artemis (see ESI). 
 This analysis showed that each of the key maleidride 
biosynthetic proteins encoded by the B. fulva cluster has a 
similar (> 38% identity) counterpart in the P. variotii cluster 
(see ESI).5 Comparisons among all five clusters show that the 
hrPKS, hydrolase, CS, 2MCD, PEBP-like and KI-like genes occur 
in all clusters. The biosynthesis of 1, however, is expected to 
be more complex than that of 4, requiring removal of one 
maleic anhydride ring and several oxidative modifications. We 
were not surprised, therefore, to find several additional 
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putative oxidase encoding genes and genes of unknown 
function in the putative cornexistin BGC. 
 
Figure 1. Cornexistin biosynthetic gene cluster. 
Gene Putative function Gene Putative function 
pv-
pks1 
Polyketide synthase 
(PKS) 
pvL11 Dienelactone hydrolase 
pvL1 Hydrolase pvL12 MFS transporter 
pvL2 2-methylcitrate 
dehydratase (2MCD) 
pvL13 Cytochrome P450 
pvL3 Ketosteroid 
isomerase-like (KI-
like) 
pvL14 Transketolase 
pvL4 MFS transporter pvL15 Aldo/keto reductase 
pvL5 Non-heme iron 
dioxygenase 
pvL16 Hypothetical protein 
pvL6 Citrate synthase-like 
(CS-like) 
pvL17 Fumarylacetoacetate hydrolase 
pvL7 Gluconolactonase pvL18 NRPS-like enzyme 
pvL8 C6 transcription 
factor 
pvR1 Phosphatidylethanolamine-
binding protein-like (PEBP-like) 
pvL9 Serine 
carboxypeptidase 
pvR2 Phosphotransferase 
pvL10 MFS transporter   
Table 1. Analysis of the cornexistin BGC from P. variotii. 
 The most highly produced compounds in WT P. variotii 
under cornexistin production conditions are a set of xanthone 
related compounds, including monodictyphenone 6, 
monodictyxanthone 7, chrysophanol 8, and three unidentified 
congeners A, B and C (Figure 2A).12 These polyketides require 
malonyl CoA for their construction by a fungal non-reducing 
PKS (nrPKS) which may compete with cornexistin biosynthesis, 
and be at least partially responsible for the low titre of 1.  
 
Figure 2. ELSD chromatograms showing the comparison of crude extracts from 11 day 
old cultures of P. variotii: A, WT strain; B, Agn∆pks strain. See ESI for detailed detection 
of 4 using HR-LCMS. 
The xanthone nrPKS was identified by comparison with other 
known xanthone pks genes (such as mdpG from Aspergillus 
nidulans,13 and claG from Cladosporium fulvum)14 and then 
disrupted using a geneticin resistance cassette to produce 
strain PVAgn∆pks. As expected this strain produced no 
xanthone related compounds 6-8 and A-C (Figure 2B), but 
produces, on average, a 2.7 fold higher cornexistin titre 
compared to WT P. variotii. Cornexistin was crystallised and its 
structure confirmed by X-ray analysis. The analysis also 
established the absolute configuration of cornexistin (Flack 
parameter 0.05) as 3S,6S,7R for the first time (Figure 3). 
  
Figure 3. X-ray structure and absolute configuration of cornexistin 1. 
The removal of overlapping xanthone-related peaks also 
allowed the isolation and characterisation of several new 
nonadride compounds: 2,2'-dihydro-2-hydroxycornexistin 15, 
isolated as its hemiacetal 9; 2,2’-dihydrocornexistin 10; and 6-
dehydroxy-2,2’dihydro-cornexistin 11 (Figure 2B). The relative 
stereochemistry of 9 was determined by comparison of 
chemical shift data obtained from ab initio calculations with 
the experimental values using the DP4 method described by 
Goodman and coworkers.15 Byssochlamic acid 4 itself was also 
detected by HR-LCMS analysis (see ESI).  
 
Scheme 1. Proposed biosynthesis of cornexistin 1. Note that absolute configuration of 
1 and 4 are known, but all others are inferred. 
Two diastereomers of dihydrocornexistin were generated by 
catalytic hydrogenation of cornexistin 1, one of which was 
identical to the natural product 10 isolated from P. variotii. It 
was not possible to assign the stereochemistry at C-2 by 
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analysis of the 1H NMR data, but detailed DFT calculations (See 
ESI) for the two hydrogenation products showed that the 
naturally occurring compound 10 is most likely the 2S epimer. 
 The pvpks1 gene encoding the hrPKS was disrupted16 by 
insertion of a hygromycin resistance cassette to produce 
PVΔpks strains. Correctly integrated transformants no longer 
produced 1, confirming that the cluster is associated with its 
biosynthesis (Figure 4B). Disruptions of the oxygenases 
encoded by pvL13 and pvL5 were also achieved in the WT 
strain which produces xanthones and various unrelated 
compounds (Figure 4). However, despite the presence of the 
unrelated compounds, disruption of pvL13 gave a strain which 
clearly no longer produced cornexistin 1, or hemiacetal 9, but 
accumulated 2,2’-dihydrocornexistin 10 and a trace of 6-
dehydroxy-2,2’-dihydrocornexistin 11 (Figure 4C). Strains with 
a disrupted pvL5 no longer produced cornexistin 1, or diol 10, 
but accumulated 6-dehydroxy-2,2’-dihydrocornexistin 11 
instead (Figure 4D). 
   
Figure 4. ELSD comparison of extracts from WT P. variotii with extracts from the 
putative late gene disruptions and P. variotii PVΔpks1. *, xanthone related; +, 
unrelated. 
 To investigate if byssochlamic acid 4 is an intermediate on 
the cornexistin pathway we fed the PVΔpks1 strain of P. 
variotii with byssochlamic acid (+)-4 purified from WT B. fulva. 
After 10 days the P. variotii mycelia and media were extracted 
with acidified EtOAc and the concentrated organic extract 
examined by LCMS. No cornexistin could be detected, but a 
mixture of the previously reported3 C-10 epimers of 
dihydrobyssochlamic acid 12 was isolated (see ESI for details). 
The Agn∆pks strain was used for all further gene 
disruptions to investigate the pathway, as the increased 
nonadride titre made the analysis more sensitive. Disruption of 
either the hydrolase (pvL1) or the citrate synthase (pvL6), to 
produce strains Agn∆pks-PVΔL1 and Agn∆pks-PVL6 
respectively, led to loss of production of cornexistin 1 (Figures 
5BC) but no accumulation of any potential intermediates. 
In contrast, disruption of the PEBP gene (pvR1) to produce 
strains Agn∆pks-PV∆R1 led to a threefold reduction in titre of 
cornexistin 1 and the production of three previously 
reported3,5 metabolites (Figure 5D). Comparison of 
chromatographic and spectroscopic propertied confirmed that 
these were the monomer 5, its hydrolysis product 5' and 13 / 
13' which arise by spontaneous decarboxylation of 5.3 
 
Figure 5. ELSD comparison of P. variotii Agn∆pks with extracts from the putative early 
gene disruptions. *Unrelated compounds. Note the ratios of 5, 5' and 13' depend on 
fermentation and extraction conditions. See references 3 and 5 for more details.  
 Disruption of the KI-like gene gave strain (AgnΔpks-PVΔL3) 
in which 5, 5' and only a trace of 13' were produced (Fig. 5E), 
again consistent with previous heterologous expression 
experiments with the KI genes in the byssochlamic acid BGC.5 
Knockout of pvL11, encoding a putative dienelactone 
hydrolase, was performed to produce AgnΔpks-PVΔL11 strains 
which still produced cornexistin 1, albeit at significantly 
reduced titre (2.6 fold less – see ESI). Disruptions of pvL7, pvL9 
and pvL14 (putatively identified as a gluconolactonase, a 
serine carboxypeptidase and a transketolase respectively) all 
led to the cessation of cornexistin 1 biosynthesis, but no 
intermediates could be identified (see ESI). 
 These results show that maleidride BGCs appear to be well-
represented in the genomes of filamentous fungi. The core 
genes encode: a PKS and a hydrolase responsible for 
polyketide biosynthesis and probable release; and a citrate-
synthase-like protein. These genes are homologous in all the 
systems examined to date and are also common with the 
squalestatin S1 BGC.17 A dehydratase then makes the key 
carboxymethyl maleic anhydride precursor 5. In the next step 
the carboxymethyl maleic anhydride precursor 5 must be 
dimerised to form either a heptadride or a nonadride. In the 
case of byssochlamic acid 4, four proteins seem to be involved 
in this step: a pair of KI-like proteins; and a pair of PEBP-like 
proteins. In previous work5 we showed that both PEBP and 
both KI encoding genes must be expressed for high production 
of 4. In the case of cornexistin 1, however, only one copy each 
of the KI and PEBP genes is present and required for 
biosynthesis. The KI-like protein(s) appears to be absolutely 
required for biosynthesis, but the presence of the PEBP-like 
protein(s) appears to improve titre during the biosynthesis of 
both 1 (KO experiments described here) and 4.5 
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 Dimerisation of the carboxymethyl maleic anhydride 
precursor 5 would be expected to lead to the formation of 
byssochlamic acid 4 as an intermediate during the biosynthesis 
of 1.5 A very low titre of 4 was observed in P. variotii (see ESI), 
but it could not be isolated and further characterised. In lieu of 
this we fed 4 isolated from WT B. fulva to the maleidride PKS 
KO strain of P. variotii but cornexistin biosynthesis was not 
restored, presumably because 4 cannot penetrate either the 
cells, or an internal compartment where biosynthesis occurs. 
 The central steps of the pathway involve the intriguing 
oxidative removal of one of the maleic anhydride moieties. 
The pvL11-encoded dienelactone hydrolase may be involved in 
this phase of biosynthesis. Its deletion reduced, but did not 
abolish, the biosynthesis of 1, indicating a possible 
spontaneous step. A similar diene lactone hydrolase (TropI) is 
implicated in maleic anhydride hydrolysis during stipitatonic 
acid biosynthesis in Talaromyces stipitatus and its KO shows a 
similar reduction in titre.18 Proteins encoded by pvL7, pvL9 and 
pvL14 are also implicated in the central steps of biosynthesis 
because their deletion leads to loss of cornexistin, but they do 
not appear to be involved in either the early or late steps of 
biosynthesis. Unfortunately no new intermediates were 
observed in these experiments, but it is plausible that a diene 
lactone hydrolase and a thiamine pyrophosphate (TPP) 
dependent transketolase are involved in these steps (see ESI). 
Further in vitro work will be required to confirm these 
proposed activities. We were also unable to discover the 
source of the 3-hydroxylation and no gene annotated in the 
present cluster appears suitable for this oxygenation step. 
 The final steps of the pathway involve decoration of the 
carbon skeleton by oxygenases encoded by pvL13 and pvL5. 
These steps involve selective hydroxylation at the 6-position by 
a non-heme iron dependent monooxygenase (pvL5) and 
dehydrogenation of the 2-2' position. This may involve initial 
P450 (pvL13) hydroxylation at C-2 to give putative 
intermediate 15 which was not observed (the more stable 
hemi-acetal 9 being isolated). It is not clear how 9 is converted 
to 1 as it appeared stable under various conditions in our 
hands. It is possible that the pvL13 encoded P450 can also 
catalyse the required elimination to form 1 - such 
multifunctional cytochrome P450 oxidases are known in other 
contexts, for example LovA apparently catalyses dual 
epoxidation and elimination during lovastatin biosynthesis19 
and AusE which catalyses three separate oxidative steps in 
spiro-lactone formation during austinol biosynthesis.20 
 We have thus elucidated many of the key steps involved in 
the biosynthesis of the herbicide cornexistin in P. variotii. 
Knockout of the xanthone biosynthetic pathway led to a 
significant increase in cornexistin titre, presumably by removal 
of competition for PKS building blocks. Several cornexistin 
pathway KO experiments produced new compounds which 
may be useful in SAR investigations and which were not 
previously available via synthetic chemistry approaches. The 
pathway confirms and amplifies our previous discoveries 
regarding the biosynthesis of maleidrides, but our results have 
also produced other intriguing possibilities surrounding the 
mechanism of nonadride production and the removal of the 
maleic anhydride moiety. Experiments to probe these 
questions are ongoing in our laboratories. 
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and was sequenced and assembled at The Genome Analysis 
Centre (Norwich, UK) under contract to Syngenta through 
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